| Literature DB >> 24217412 |
Erika L Flannery1, Arnab K Chatterjee, Elizabeth A Winzeler.
Abstract
Malaria elimination has recently been reinstated as a global health priority but current therapies seem to be insufficient for the task. Elimination efforts require new drug classes that alleviate symptoms, prevent transmission and provide a radical cure. To develop these next-generation medicines, public-private partnerships are funding innovative approaches to identify compounds that target multiple parasite species at multiple stages of the parasite life cycle. In this Review, we discuss the cell-, chemistry- and target-based approaches used to discover new drug candidates that are currently in clinical trials or undergoing preclinical testing.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24217412 PMCID: PMC3941073 DOI: 10.1038/nrmicro3138
Source DB: PubMed Journal: Nat Rev Microbiol ISSN: 1740-1526 Impact factor: 60.633